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We tested the hypothesis that c 
analogue of ticlopidine and an P antagonist, is 
effective in 4jieve11iing spontanea and cplnephrine 
(E)-induced cyclic flow variations (ms), the 
phenomenon caused by recurrent platelet aggregation and 
dislodgement at arterial sites th stenosis and 
endothelial injury. Fourteen ane etized dogs were 
instrumented with plastic constrictors around the LAD at 
the site of endothelial injury and developed coronary 
CFVS. C (10 &kg i.v. bolus + 2.5 mg/kg/hour i.v. 
infusion) was given at 30 minutes (Group I, n=7! and 3 
hours (Group II, n-7) after the establishment of CFVs, 
respectively, and eliminated CFWs in all cases. titer 
the abolition of CFVs, E was infused to the 7 group I 
dogs and resulted in a rise in plasma E concentrations 
from 0.590.2 rig/ml at baseline to 4125.6 rig/ml 
(p<O.O01), but only 2 dogs had CFVs restored. Plasma 
thromboxane B (the stable metabolite of thrombox~~e A ) 
concentration2 increased from 66+25 m/ml to 205+1$9 
pg/ml in the distal to the stenosis after 3 hour 
ot reduced by C, (24LOZ132 pg/ml). 
Serotonin accumulation at LTQ sites with stenoses was 
also not reduced by C. hx viva plat gregation 
induced by ADP was inhibited, by U46619 mimetic) 
reduced by 40%, and by serotonin reduce after C. 
Thus, C eliminates CFVs and prevents their restoration 
by epinephrine in this experimental model possibly by 
the inhibition and attenuation of ADP-, thromboxane AZ-, 
and serotonin-induced platelet aggregation. 
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hours and the explants ware washed and incubated for 15 
min. with cold thymidine. The arteries were digested and 
aliquots were counted in a intillation counter. 
Protein content was determined. 
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Our results indicate that giopeptin is a potent 
inhibitor of smooth muscle cell proliferation in vitro. 
We recently showed that fish 011 attenuated the development of 
atherosclerosis in the lipid fed rabbit. A potential mechanism of 
action was its antiplatelet effects since flsh oil decreased platelet 
aggregation and prolonged bleedlng time To test this hypothesis, 
we studied the dose response effects of another antiplatelet 
agent, asioirin (ASA). Four different doses of ASA were glven 
by dally gavage for 12 weeks to 36 male New Zealand rabbtts: 
I mg/kg (group A- 1 I, IO mg/kg (A-lo), 30 mg/kg (A-30) and 
60 mg/kg (A-601, whlle 10 rabbits served as Control (group C, 
wlthout ASA) All rabbi!s were fed a high ChOleSterOl diet (0 3% 
cholesterol plus 3% soy bean oil). We measured bleeding time 
(BT) (average control = 58 : 10 set), platelet aggregation (P.A.1 
( average control = 0.82 I 0. I7 1, serum cholesterol (CH) and 
serum ASA levels. After sacrifice of the rabbits, percent 
involvement of the atherosclerotic aorta ( A 1 was determined by 
planlmetry. Data are shown below. 
At 12 weeks C A-10 A-30 A-60 
CH(mg/dl) 10842407 I 16tzl37 6942332 8492375 652~418 
A(%) 19:12 41~17** 23220 16210 16215 
ASA(mg/dl) 0 3 (b&S** 3.9+0.7**9.2~1.1*“16.3t4.S** 
delta BT(sec) -2: 13 lo:24 12:13* 27213” 2S:23* 
delta P.A. -.OSt. I 6 .C3~.23 072.28 .08~.26 .38:.29” 
** vs group C, P < 0.0 1; * vs control level, P < 0.05 
Thus, ASA was lneffectlve In attenuatlng aortic atherosr:erosls ln the 
llpld fed rabblt.Since ASA altered platelet aggregation and bleeding tfme 
to the same extent as fish oil, this result Suggests that the Previously 
demonstrated protective effects of fish 011 on experimental athero- 
sclerosis are due to a mechanism other than Its antiplatelet effects. 
